The present invention is concerned with aryl-4-ethynyl-isoxazole derivatives of formula I
wherein R
1
to R
5
are as described in the specification and pharmaceutically acceptable salt thereof. This class of compounds has high affinity and selectivity for GABA A α5 receptor binding sites, being useful as a cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.
本发明涉及式I的芳基-4-乙炔-异恶唑衍生物,其中R1至R5如规范中所述,并且其药用盐。这类化合物具有高亲和力和选择性结合到GABA A α5受体结合位点,可用作认知增强剂或用于治疗阿尔茨海默病等认知障碍。
Novel gamma-secretase inhibitors
申请人:Bettati Michela
公开号:US20060189666A1
公开(公告)日:2006-08-24
Compounds of Formula (I): inhibit the processing of APP by gamma-secretase, and hence are useful for treatment or prevention of Alzheimer's disease.
式(I)的化合物抑制γ-分泌酶对APP的加工,因此对于治疗或预防阿尔茨海默病有用。
Gamma-secretase inhibitors
申请人:Merck Sharp & Dohme Limited
公开号:US07452899B2
公开(公告)日:2008-11-18
Compounds of Formula (I): inhibit the processing of APP by gamma-secretase, and hence are useful for treatment or prevention of Alzheimer's disease.